Zealand Pharma A/S Zealand Pharma A/S

Zealand Pharma A/S

ZEAL

Peringkat dalam Saham #5479
Zealand Pharma A/S is a Danish biotechnology firm dedicated to the... Zealand Pharma A/S is a Danish biotechnology firm dedicated to the identification, progression, and market introduction of peptide-based therapeutics. The company concentrates its efforts on treatments for gastrointestinal and metabolic ailments, as well as other specialized conditions where current medical options are insufficient. Its commercialized product, Dasiglucagon, is an injectable solution provided in a pre-filled syringe or autoinjector, used to address severe hypoglycemia. Furthermore, Zealand Pharma is actively developing Dasiglucagon for inclusion in bi-hormone artificial pancreas systems that integrate both insulin and dasiglucagon. The compound Dasiglucagon is also undergoing late-stage (Phase III) clinical trials for congenital hyperinsulinism. Another significant asset in its development pipeline is glepaglutide, a long-acting GLP-2 analog, which is likewise in Phase III clinical studies for treating short bowel syndrome. Founded in 1998 and headquartered in Copenhagen, Denmark, Zealand Pharma A/S maintains strategic alliances with a range of partners, including Sanofi-Aventis Deutschland GmbH, Boehringer Ingelheim International GmbH, Alexion Pharmaceuticals, Inc., and Beta Bionics, Inc.
Harga Saham
$35.23
Kapitalisasi Pasar
$2.45B
Perubahan (1 hari)
-1.68%
Perubahan (1 tahun)
-50.79%
Negara
DK
Perdagangan Zealand Pharma A/S (ZEAL)

Kategori

Healthcare
Harga ZEAL dengan kapitalisasi pasar B
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
$35.23
Kapitalisasi pasar dari Zealand Pharma A/S(ZEAL)
Kapitalisasi Pasar: $2.45B
Per October 2026, Zealand Pharma A/S memiliki kapitalisasi pasar sebesar $2.45B. Ini menjadikan Zealand Pharma A/S sebagai perusahaan 5479th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Zealand Pharma A/S dari 2013 hingga 2026
ZEAL dibandingkan dengan 5 teratas stocks paling populer
Harga ZEAL Aset B Pasar B Hasil
Zealand Pharma A/S Zealand Pharma A/S
$72,511.01 $2.42B
$5.167T +213,167.67%
Zealand Pharma A/S Zealand Pharma A/S
$70,374.27 $2.42B
$5.015T +206,883.16%
Zealand Pharma A/S Zealand Pharma A/S
$57,654.75 $2.42B
$4.108T +169,472.79%
Zealand Pharma A/S Zealand Pharma A/S
$54,756.88 $2.42B
$3.902T +160,949.64%
Zealand Pharma A/S Zealand Pharma A/S
$37,742.14 $2.42B
$2.689T +110,906.31%